title: Fludarabine and high dose cytarabine (FLA): a well tolerated salvage regimen in acute myeloid leukaemia.
authors.affiliation: Division of Haematology and Medical Oncology, Peter MacCallum Cancer Institute, East Melbourne, Vic.
authors.forename: A H
authors.initials: AH
authors.lastname: Strickland
authors.forename: C
authors.initials: C
authors.lastname: Seymour
authors.forename: H M
authors.initials: HM
authors.lastname: Prince
authors.forename: M
authors.initials: M
authors.lastname: Wolf
authors.forename: S
authors.initials: S
authors.lastname: Juneja
authors.forename: E H
authors.initials: EH
authors.lastname: Januszewicz
mesh_terms: D000208:Acute Disease; D000328:Adult; D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D003561:Cytarabine / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007951:Leukemia, Myeloid / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D016879:Salvage Therapy; D014740:Vidarabine / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D000964:Antimetabolites, Antineoplastic; D000970:Antineoplastic Agents; D003561:Cytarabine; D014740:Vidarabine; C024352:fludarabine